dc.contributor.author | Rutkowski, S | |
dc.contributor.author | Modena, P | |
dc.contributor.author | Williamson, D | |
dc.contributor.author | Kerl, K | |
dc.contributor.author | Nysom, K | |
dc.contributor.author | Pizer, B | |
dc.contributor.author | Bartels, U | |
dc.contributor.author | Puget, S | |
dc.contributor.author | Doz, F | |
dc.contributor.author | Michalski, A | |
dc.contributor.author | von Hoff, K | |
dc.contributor.author | Chevignard, M | |
dc.contributor.author | Avula, S | |
dc.contributor.author | Murray, MJ | |
dc.contributor.author | Schoenberger, S | |
dc.contributor.author | Czech, T | |
dc.contributor.author | Schouten-van Meeteren, AYN | |
dc.contributor.author | Kordes, U | |
dc.contributor.author | Kramm, CM | |
dc.contributor.author | van Vuurden, DG | |
dc.contributor.author | Hulleman, E | |
dc.contributor.author | Janssens, GO | |
dc.contributor.author | Solanki, GA | |
dc.contributor.author | van Veelen, M-LC | |
dc.contributor.author | Thomale, U | |
dc.contributor.author | Schuhmann, MU | |
dc.contributor.author | Jones, C | |
dc.contributor.author | Giangaspero, F | |
dc.contributor.author | Figarella-Branger, D | |
dc.contributor.author | Pietsch, T | |
dc.contributor.author | Clifford, SC | |
dc.contributor.author | Pfister, SM | |
dc.contributor.author | Van Gool, SW | |
dc.date.accessioned | 2018-05-29T08:55:31Z | |
dc.date.issued | 2018-08-01 | |
dc.identifier.citation | Lancet Oncology | |
dc.identifier.issn | 1470-2045 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/1692 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | ELSEVIER SCIENCE INC | |
dc.rights.uri | https://www.rioxx.net/licenses/under-embargo-all-rights-reserved | |
dc.title | Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour Group | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2018-05-08 | |
rioxxterms.licenseref.uri | https://www.rioxx.net/licenses/under-embargo-all-rights-reserved | |
rioxxterms.licenseref.startdate | 2018-05-08 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Lancet Oncology | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Glioma Team | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Glioma Team | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Glioma Team | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Glioma Team | |
pubs.embargo.terms | Not known | |
icr.researchteam | Glioma Team | |
dc.contributor.icrauthor | Jones, Chris | |